News

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech…
Read More...

WuXi Biologics and ImmuneOncia Therapeutics announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnership in the development and manufacturing of…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that it has completed submission of…
Read More...

Eisai Co., Ltd. and Biogen Inc. announced that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of early Alzheimer’s disease (AD), was granted…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited, a vaccine…
Read More...

Karyopharm Therapeutics Inc. and the Menarini Group announced their entry into an exclusive licensing agreement whereby Menarini will commercialize NEXPOVIO, Karyopharm's…
Read More...

Sedana Medical AB (publ) announces that the company has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to initiate phase III pivotal…
Read More...

Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced that it has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a premier…
Read More...

Novo Nordisk announced that the acquisition of Dicerna Pharmaceuticals, Inc. announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender…
Read More...

Ionis Pharmaceuticals, Inc. announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis' investigational antisense medicine for…
Read More...

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has tentatively approved the Company's Abbreviated New Drug Application for Vasopressin injection,…
Read More...

Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection. The…
Read More...

Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization…
Read More...

Evotec SE announced that the Company has received a US$ 18 m grant from the Bill & Melinda Gates Foundation (Seattle, WA, USA, “the foundation”) for the integrated discovery and…
Read More...

SAB Biotherapeutics, a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies…
Read More...

BioMarin Pharmaceutical Inc. and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a…
Read More...

Valneva SE a specialty vaccine company, today announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.…
Read More...

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced the launch of the NAV3-33 Phase 3 clinical…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID (nirmatrelvir tablets…
Read More...

Alpine Immune Sciences, Inc. and Horizon Therapeutics plc announced an exclusive license and collaboration agreement for the development and commercialization of up to four preclinical…
Read More...